
ESMO/LinkedIn
Jun 26, 2025, 04:50
ESMO Updated Clinical Practice Guideline for Oncogene-Addicted Metastatic NSCLC
ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“Updated ESMO Clinical Practice Guideline recommendations in oncogene-addicted metastatic NSCLC: more Targeted Therapy agents now available in 1L or at resistance.”
More posts featuring ESMO on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 18, 2025, 01:00
Jul 18, 2025, 00:39
Jul 18, 2025, 00:10
Jul 17, 2025, 23:43
Jul 17, 2025, 18:57
Jul 17, 2025, 18:43
Jul 17, 2025, 18:15